Home / Funds / Voleon Capital Management LP
Voleon Capital Management LP
The short positions this fund discloses today, across every market.
8 open positions
4 Markets
July 21, 2026 Last disclosure
549300EJ1ZB4YYIOMD56 LEI
| Issuer | Market | % of capital | Since |
|---|---|---|---|
| Zealand Pharma A/S | Denmark | 1.11% | May 19, 2026 |
| B&M European Value Retail S.A. | Germany | 0.79% | April 20, 2026 |
| Oryzon Genomics, S.A. | Spain | 0.63% | July 3, 2026 |
| Gubra A/S | Denmark | 0.59% | March 23, 2026 |
| Lang & Schwarz Aktiengesellschaft | Germany | 0.59% | February 2, 2022 |
| Tubacex, S.A. | Spain | 0.59% | June 30, 2026 |
| Medigene AG | Germany | 0.55% | December 4, 2017 |
| Atos Group | France | 0.50% | July 21, 2026 |
History of disclosures
| Date | Issuer | Market | % of capital | End of publication |
|---|---|---|---|---|
| March 15, 2021 | Eurotech SPA | Italy | 1.30% | still open |
| March 15, 2021 | Quantum Genomics | France | 1.14% | June 14, 2021 |
| March 15, 2021 | Erytech Pharma | France | 0.49% | still open |
| March 15, 2021 | Phaxiam Therapeutics | France | 0.49% | March 23, 2021 |
| March 12, 2021 | Solocal Group | France | 0.61% | April 15, 2021 |
| March 12, 2021 | Oncopeptides AB | Sweden | 0.61% | still open |
| March 12, 2021 | 4D Pharma PLC | United Kingdom | 0.60% | still open |
| March 12, 2021 | Immunovia AB (publ) | Sweden | 0.57% | still open |
| March 12, 2021 | Nicox SA | France | 0.52% | May 19, 2021 |
| March 11, 2021 | Amoeba | France | 0.58% | still open |
| March 11, 2021 | Erytech Pharma | France | 0.57% | still open |
| March 11, 2021 | Phaxiam Therapeutics | France | 0.57% | March 23, 2021 |
| March 11, 2021 | Oncopeptides AB | Sweden | 0.53% | still open |
| March 10, 2021 | Quantum Genomics | France | 1.08% | June 14, 2021 |
| March 10, 2021 | Digital Bros SPA | Italy | 0.58% | still open |
| March 10, 2021 | 4D Pharma PLC | United Kingdom | 0.52% | still open |
| March 9, 2021 | Biophytis | France | 1.25% | June 18, 2021 |
| March 9, 2021 | Eurotech SPA | Italy | 1.25% | still open |
| March 9, 2021 | Erytech Pharma | France | 0.65% | still open |
| March 9, 2021 | Phaxiam Therapeutics | France | 0.65% | March 23, 2021 |
| March 8, 2021 | Eurotech SPA | Italy | 1.47% | still open |
| March 8, 2021 | Metro Bank PLC | United Kingdom | 0.87% | still open |
| March 8, 2021 | Digital Bros SPA | Italy | 0.63% | still open |
| March 8, 2021 | Solocal Group | France | 0.52% | April 15, 2021 |
| March 4, 2021 | Erytech Pharma | France | 0.70% | still open |
| March 4, 2021 | Phaxiam Therapeutics | France | 0.70% | March 23, 2021 |
| March 3, 2021 | Quantum Genomics | France | 0.92% | June 14, 2021 |
| March 3, 2021 | Borussia Dortmund Gmbh & CO. Kommanditgesellschaft AUF Aktien | Germany | 0.46% | still open |
| March 2, 2021 | Erytech Pharma | France | 0.72% | still open |
| March 2, 2021 | Amoeba | France | 0.60% | still open |
| March 2, 2021 | Borussia Dortmund Gmbh & CO. Kommanditgesellschaft AUF Aktien | Germany | 0.55% | still open |
| March 1, 2021 | Metro Bank PLC | United Kingdom | 0.91% | still open |
| March 1, 2021 | DBV Technologies | France | 0.49% | March 3, 2021 |
| February 26, 2021 | Digital Bros SPA | Italy | 0.48% | still open |
| February 25, 2021 | Eurotech SPA | Italy | 1.60% | still open |
| February 25, 2021 | Biophytis | France | 1.30% | June 18, 2021 |
| February 25, 2021 | Navya | France | 1.21% | August 3, 2021 |
| February 25, 2021 | Metro Bank PLC | United Kingdom | 0.80% | still open |
| February 25, 2021 | Betsson AB | Sweden | 0.00% | still open |
| February 24, 2021 | Navya | France | 0.94% | August 3, 2021 |
| February 24, 2021 | Metro Bank PLC | United Kingdom | 0.77% | still open |
| February 24, 2021 | Erytech Pharma | France | 0.69% | still open |
| February 24, 2021 | Phaxiam Therapeutics | France | 0.69% | March 23, 2021 |
| February 24, 2021 | DBV Technologies | France | 0.59% | March 3, 2021 |
| February 23, 2021 | Erytech Pharma | France | 0.70% | still open |
| February 23, 2021 | Phaxiam Therapeutics | France | 0.70% | March 23, 2021 |
| February 22, 2021 | Navya | France | 0.73% | August 3, 2021 |
| February 22, 2021 | DBV Technologies | France | 0.63% | March 3, 2021 |
| February 22, 2021 | Immunovia AB (publ) | Sweden | 0.60% | still open |
| February 22, 2021 | Strategic Partners A/S | Denmark | 0.58% | February 22, 2021 |
The funds short on the same companies
- Citadel Advisors LLC 2 companies in common
- AHL Partners LLP 1 company in common
- ActusRayPartners Limited 1 company in common
- Capital Fund Management 1 company in common
- Citadel Advisors II LLC 1 company in common
- Connor Clark & Lunn Investment Management Ltd 1 company in common
- D. E. Shaw & Co., L.P. 1 company in common
- GSA Capital Partners LLP 1 company in common
- Jennison Associates LLC 1 company in common
- Jupiter Asset Management Limited 1 company in common
- Marshall Wace LLP 1 company in common
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Voleon Capital Management LP, data as at July 21, 2026, https://www.quivad.com/detenteur/voleon-capital-management-lp?page=64